Primary Endpoint Changes Common in Cancer Trials

Primary Endpoint Changes Common in Cancer Trials

Changes to primary endpoints in phase 3 cancer trials occur frequently and are often undisclosed in study manuscripts, new research shows. Among 755 randomized controlled cancer trials registered in ClinicalTrials.gov, 145 (19%) had their primary endpoints changed after the trial…

Read More